Evidence map›Paper›PMID 30745560›Full record

ArticleTranslational psychiatry2019

Multimodel inference for biomarker development: an application to schizophrenia.

Jason D Cooper, Sung Yeon Sarah Han, Jakub Tomasik, Sureyya Ozcan, Nitin Rustogi, Nico J M van Beveren, F Markus Leweke, Sabine Bahn

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05257720 (Evaluation of the Role of Neurodegeneration in Treatment Resistant Schizophrenia With GFAP and S100B), which is not on this map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05257720 completednot on this mapstarted 2022, after this paper: background citation

Evaluation of the Role of Neurodegeneration in Treatment Resistant Schizophrenia With GFAP and S100B

Typeobservational_patient_registrySponsorIstanbul Saglik Bilimleri UniversityRan2022 to 2022Enrolled178ConditionsSchizophreniaArmsGFAP, S100B
3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 4 countries.

Jason D CooperDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK. jdc43@cam.ac.uk.
Sung Yeon Sarah HanDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Jakub TomasikDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Sureyya OzcanDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Nitin RustogiDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
Nico J M van BeverenDepartment of Neuroscience, Erasmus Medical Centre, Rotterdam, Netherlands.
F Markus LewekeBrain and Mind Centre, University of Sydney, Sydney, Australia.
Sabine BahnDepartment of Chemical Engineering and Biotechnology, University of Cambridge, Cambridge, UK.
University of Cambridge · GBErasmus University Rotterdam · NLUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the present study, to improve the predictive performance of a model and its reproducibility when applied to an independent data set, we investigated the use of multimodel inference to predict the probability of having a complex psychiatric disorder. We formed training and test sets using proteomic data (147 peptides from 77 proteins) from two-independent collections of first-onset drug-naive schizophrenia patients and controls. A set of prediction models was produced by applying lasso regression with repeated tenfold cross-validation to the training set. We used feature extraction and model averaging across the set of models to form two prediction models. The resulting models clearly demonstrated the utility of a multimodel based approach to make good (training set AUC > 0.80) and reproducible predictions (test set AUC > 0.80) for the probability of having schizophrenia. Moreover, we identified four proteins (five peptides) whose effect on the probability of having schizophrenia was modified by sex, one of which was a novel potential biomarker of schizophrenia, foetal haemoglobin. The evidence of effect modification suggests that future schizophrenia studies should be conducted in males and females separately. Future biomarker studies should consider adopting a multimodel approach and going beyond the main effects of features.

Indexed as

Sex FactorsAdultBiomarkersFemaleHumansMaleModels, StatisticalProteomicsRegression AnalysisReproducibility of ResultsRisk FactorsROC CurveSchizophreniaYoung AdultBiomarkers

Identifiers

PMID30745560
PMCPMC6370882
OpenAlexW2912281587

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.